v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,128 $ 20,431
Accounts receivable, net 116,875 97,551
Inventories, net 70,606 72,155
Fair value of derivative instruments 0 823
Contract assets 9,608 3,555
Prepaid expenses and other current assets 13,253 9,520
Total current assets 216,470 204,035
Property, plant and equipment, net 2,511,110 2,488,682
Operating lease right-of-use assets, net 33,453 9,827
Goodwill 305,553 305,553
Identifiable intangible assets, net 125,257 132,362
Fair value of derivative instruments 51,790 64,517
Other assets 607 564
Total assets 3,244,240 3,205,540
Current liabilities:    
Accounts payable 48,835 37,992
Accrued liabilities 102,448 93,873
Contract liabilities 71,917 57,109
Total current liabilities 223,200 188,974
Long-term debt, net of unamortized debt issuance cost 1,747,912 2,720,019
Operating lease liabilities 34,026 6,754
Deferred tax liabilities 65,258 57,155
Other liabilities 2,052 3,545
Total liabilities 2,072,448 2,976,447
Commitments and contingencies (Note 13)
Stockholders’ Equity:    
Common stock, par value $0.01 per share; 750,000,000 shares of common stock authorized, 77,400,000 and 59,000,000 shares of common stock issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 774 590
Additional paid-in capital 956,465 33,189
Retained earnings 214,553 195,314
Total stockholders’ equity 1,171,792 229,093
Total liabilities and stockholders’ equity $ 3,244,240 $ 3,205,540
Common stock, shares outstanding (in shares) 77,400,000 59,000,000

Source